Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436What this trial is testingStudy to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin MalignanciesWho this might be right forMerkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more Replimune, Inc. 69
Not applicableUnknownNCT03092830What this trial is testingMolecular Characterization of Cutaneous TumorsWho this might be right forSquamous Cell CarcinomaBasal Cell Carcinoma Rabin Medical Center 500
Early research (Phase 1)Study completedNCT00103246What this trial is testingPhotodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis FungoidesWho this might be right forLymphomaNon-melanomatous Skin CancerPrecancerous Condition Case Comprehensive Cancer Center 43
Early research (Phase 1)Active Not RecruitingNCT04616248What this trial is testingIn Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more University of Southern California 14
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Not applicableStudy completedNCT00476905What this trial is testingSpectral Diagnosis of Cutaneous MalignancyWho this might be right forSkin Cancer M.D. Anderson Cancer Center 350
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808515What this trial is testingA Study Comparing Cemiplimab-based Treatments for Adult Participants With Locally Advanced Basal Cell Skin Cancer (laBCC)Who this might be right forLocally Advanced Basal Cell Carcinoma Regeneron Pharmaceuticals 135
Early research (Phase 1)Active Not RecruitingNCT03816332What this trial is testingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more National Cancer Institute (NCI) 12
Early research (Phase 1)UnknownNCT03982212What this trial is testingA Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible TumorsWho this might be right forCutaneous Squamous Cell CarcinomaSquamous Cell CarcinomaBasal Cell Carcinoma University of Kansas Medical Center 10
Not applicableNot Yet RecruitingNCT07361666What this trial is testingImpact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor RecurrenceWho this might be right forBasal Cell Carcinoma of SkinCutaneous Squamous Cell Carcinoma (CSCC)Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)+4 more Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
Not applicableUnknownNCT03822988What this trial is testingACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTSWho this might be right forAdvance DirectivesOncologySkin Cancer+4 more Central Hospital, Nancy, France 150
Testing effectiveness (Phase 2)Looking for participantsNCT07251413What this trial is testingCemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell CarcinomaWho this might be right forCutaneous Basal Cell Carcinoma Instituto Oncológico Dr Rosell 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50
Not applicableLooking for participantsNCT06536257What this trial is testingPersonalised Immunotherapy PlatformWho this might be right forMelanomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+2 more Melanoma Institute Australia 1,000
Not applicableEnded earlyNCT03886181What this trial is testingAlpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)Who this might be right forSkin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm Alpha Tau Medical LTD. 2
Not applicableStudy completedNCT00005660What this trial is testingThe Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive DiseasesWho this might be right forBasal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis National Cancer Institute (NCI) 130
Not applicableActive Not RecruitingNCT06608511What this trial is testingLiquid Biomarker Study in Melanoma and Non-Melanoma Skin CancersWho this might be right forSkin CancerMelanoma (Skin Cancer)Basal Cell Carcinoma of Skin+3 more University of Wisconsin, Madison 20
Testing effectiveness (Phase 2)Study completedNCT01835626What this trial is testingPhase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell CarcinomaWho this might be right forLocally Advanced Basal Cell CarcinomaSkin CancerCutaneous Malignancy Sue Yom 24
Testing effectiveness (Phase 2)Looking for participantsNCT05896839What this trial is testingImmunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more National Cancer Institute (NCI) 16